PrEP Awareness Program for HIV Prevention in Black Women
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how effectively a program can increase awareness and use of PrEP, a medication that helps prevent HIV, among Black women. Researchers will pilot a program at a GYN residency clinic and use a social media campaign to determine if these efforts improve PrEP uptake. The trial suits Black cisgender women eligible for PrEP according to CDC guidelines. As an unphased study, this trial offers participants the opportunity to contribute to important research that could enhance HIV prevention strategies for Black women.
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this program is safe for participants?
Research shows that the GYN Residency Training is safe for participants. Studies have found that after this training, most residents feel more confident and informed about prescribing PrEP, a medication that helps prevent HIV. This indicates that the training is well-received and does not cause harm.
For the Social Media Campaign, past efforts like PrEP4Love have successfully reached millions of people without any reported safety issues. These campaigns aim to raise awareness and do not involve taking any medication, so they are considered safe.
Both the training and the social media campaigns have been used before without causing problems. They focus on education and awareness, which are generally safe activities.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a fresh approach to increasing the use of PrEP (pre-exposure prophylaxis) for HIV prevention among Black women. Unlike traditional methods, this trial combines GYN residency training with a social media campaign to boost awareness and uptake of PrEP. The layered strategy aims to first strengthen the healthcare provider's role in prescribing PrEP and then leverage social media to engage Black women directly, fostering greater demand and awareness. This dual approach could potentially bridge gaps in current awareness and accessibility, making it a promising avenue for enhancing HIV prevention efforts in this community.
What evidence suggests that this trial's treatments could be effective for HIV prevention in Black women?
This trial will evaluate two separate interventions: GYN residency training and a social media campaign. Research has shown that training for GYN residents can improve their understanding of HIV prevention and increase the use of PrEP, a pill that helps prevent HIV. One study found that trainees knew more about PrEP after receiving education on it. Another study confirmed that PrEP training during residency is effective and important for increasing its use.
Regarding the social media campaign, studies have shown that well-executed campaigns can improve how often people start and continue using PrEP. For example, a community-driven campaign successfully connected with the target audience using engaging visuals and relatable spokespersons. Another study emphasized that such campaigns are vital for raising awareness and encouraging consistent use of PrEP in the community.12367Who Is on the Research Team?
Amy Corneli, MPH, PhD
Principal Investigator
Duke University
Meredith Clement, MD
Principal Investigator
Louisiana State University Health Sciences Center
Are You a Good Fit for This Trial?
This trial is for LSU GYN residents and Black cisgender women who meet the CDC guidelines for PrEP, a medication that helps prevent HIV. It's designed to evaluate an initiative aimed at increasing PrEP use among these women in New Orleans.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention
Collection of routine PrEP uptake data to establish a baseline for PrEP prescribing at the GYN residency clinics and local PrEP clinics
Implementation
Implementation of the combined-care model at the LSU GYN residency clinic at UMCNO and social media campaign in the NOLA area
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- GYN Residency Training
- Social Media Campaign
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Collaborator
National Institute of Mental Health (NIMH)
Collaborator